Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017

Table 2 Treatment outcomes for participants finishing follow-up

	n (%)
	Benguela		Zaire		Lunda Sul
	DP^b	ASAQ^a	AL^a	ASAQ^a	AL^a	DP^b
	n = 85	n = 91	n = 94	n = 90	n = 91	n = 89
Treatment failure	5 (6)	1 (1)	7 (7)	16 (18)	9 (10)	0
Early treatment failure	0	0	0	0	0	0
Late treatment failure	5 (6)	1 (1)	7 (7)	16 (18)	9 (10)	0
Recrudescence	0	0	4 (4)	5 (6)	3 (3)	0
Day 21	0	0	1 (1)	5 (6)	3 (3)	0
Day 28	0	0	3 (3)	0	0	0
Day 35	0	–	–	–	–	0
Day 42	0	–	–	–	–	0
Reinfection	5 (6)	1 (1)	3 (3)	11 (12)	6 (7)	0
Day 21	0	0	0	7 (8)	2 (2)	0
Day 28	0	1 (1)	3 (3)	4 (4)	4 (4)	0
Day 35	2 (2)	–	–	–	–	0
Day 42	3 (4)	–	–	–	–	0
Adequate clinical and parasitological response	80 (94)	90 (99)	87 (93)	74 (82)	82 (90)	89 (100)

AL artemether–lumefantrine, ASAQ artesunate–amodiaquine, DP dihydroartemisinin–piperaquine
^a28-day follow-up
^b42-day follow-up

ISSN: 1475-2875